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Abstract
The possibility that some combinations of mtDNA polymorphisms, previously associated with Leber’s hereditary optic neuropathy
(LHON), may affect mitochondrial respiratory function was tested in osteosarcoma-derived transmitochondrial cytoplasmic hybrids
(cybrids). In this cellular system, in the presence of the same nuclear background, different exogenous mtDNAs are used to repopulate a
parental cell line previously devoid of its original mtDNA. No detectable differences in multiple parameters exploring respiratory function
were observed when mtDNAs belonging to European haplogroups X, H, T and J were used. Different possible explanations for the
previously established association between haplogroup J and LHON 11778/ND4 and 14484/ND6 pathogenic mutations are discussed,
including the unconventional proposal that mtDNA haplogroup J may exert a protective rather than detrimental effect.
D 2002 Elsevier Science B.V. All rights reserved.
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1. Introduction
Analysis of human mtDNA variation has identified
specific combinations of polymorphisms that have been
used to systematically classify mtDNAs into haplogroups,
and to study origin, dispersal and evolution of human
populations [1,2]. Some authors have further suggested
that certain mtDNA population polymorphisms may interact
with environmental factors and/or mtDNA pathogenic muta-
tions, and therefore that mtDNAs belonging to different
haplogroups could result in mitochondria with differential
functionality [2]. In this regard, the most debated case is the
plethora of mtDNA nucleotide changes that have been
associated with Leber’s hereditary optic neuropathy
(LHON) [2–10]. Three of these mutations, at positions
11778/ND4, 3460/ND1 and 14484/ND6, are now unani-
mously considered as pathogenic for most of the LHON
cases worldwide [2,11]. At least five other transitions at
positions 4216/ND1, 13708/ND5, 15257/cytb, 15812/cytb
and 4917/ND2, defined as ‘‘secondary or intermediate
mutations’’ [2], are polymorphisms of European populations
[12]. Indeed, they occur in specific combinations within
haplogroups J (4216/ND1, 13708/ND5, and in more recent
sub-branches 15257/cytb and 15812/cytb) and T (4216/ND1
and 4917/ND2)[12]. Both haplogroups J and T have
diverged from a more ancient mtDNA lineage defined by
the 4216/ND1 change only [12]. These five polymorphisms
were initially associated with LHON on the basis of their
more frequent recurrence in LHON pedigrees compared to
the general population [3–6]. Subsequently, a more rational
investigation was performed to test their association with
LHON and three laboratories published systematic haplo-
type and phylogenetic analyses of LHON patients from the
USA [13], Italy [14] and Germany [15]. These independent
studies showed a preferential association of the pathogenic
mutations 11778/ND4 and 14484/ND6 with haplogroup J.
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This association was particularly striking with the 14484/
ND6 mutation. On the other hand, LHON pedigrees carrying
the 3460/ND1 mutation seemed widely distributed among all
haplogroups [13,14]. The currently favored interpretation is
that the haplogroup J may lead to increased penetrance of the
LHON pathogenic mutations 11778/ND4 and 14484/ND6
[13,14]. A more non-specific effect of the haplogroup J as a
risk factor for neurodegenerative diseases in general, has also
been suggested [9]. However, genetic and clinical investiga-
tions by other authors found no evidence for influence of the
‘‘secondary mutations’’, including those clustered in hap-
logroups J and T, on the pathogenesis and clinical expression
of LHON [7,8,10,16]. Intriguingly, haplogroup J may also be
associated with successful aging, as a recent study carried
out on Italian centenarians has suggested [17]. Moreover,
another recent report described the high prevalence of
haplogroup T in individuals with reduced spermatozoa
motility and of haplogroup H in those with normal motility
and these associations correlated with significant differences
in haplogroup-specific respiratory chain performance [18].
In the present study, we used the transmitochondrial
cytoplasmic hybrid (cybrid) technology [19] to compare,
in the nuclear background of the osteosarcoma 143B.TK-
parental cell line, the respiratory chain function of mtDNA-
less rho0 cell lines (206) repopulated with mitochondria
from control fibroblasts with different mtDNA haplogroups.
2. Materials and methods
2.1. Cells
Fibroblast cell lines have been obtained, after informed
consent, from skin biopsies of normal subjects. Fibroblast
cell lines were then enucleated and fused with the mtDNA-
less 206 rho0 cells following the described method [19].
Positive mtDNA re-population was identified by picking up
growing clones (a minimum of four successful clones for
each fusion) in selective medium: normal DMEM supple-
mented with 5% dialyzed fetal bovine serum (dFBS)
(Seromed-Biochrom, Berlin), 0.1 mg/ml bromodeoxyuri-
dine and no uridine. The re-population of the 206 rho0 cells
with the fibroblast mtDNA was confirmed by screening for
the diagnostic mutations (Table 1) identified in the mtDNA
of the fibroblast cell line. The human cell line 143B.TK-
(obtained from G. Attardi as kind gift), from which the 206
rho0 line was developed [19], was used as control. To ensure
complete stabilization of mtDNA amount, functional assess-
ment of selected clones was carried out only after at least 3
months of clone cycling.
2.2. High resolution RFLP analysis and haplogroup
classification of mtDNAs
To determine high resolution RFLP haplotypes, the entire
mtDNA from the fibroblast cell lines and the osteosarcoma
143B.TK-parental cell line was amplified in nine overlapping
fragments by the use of PCR and the primer pairs previously
described [14]. Each of the nine PCR segments was then
digested with 14 restriction endonucleases (AluI, AvaII,
BamHI, DdeI, HaeII, HaeIII, HhaI, HincII, HinfI, HpaI,
MspI, MboI, RsaI, TaqI) (Promega, Madison, WI, USA). In
addition, mtDNAs were screened for the presence/absence of
the BstOI site at np 13704, the AccI sites at nps 14465 and
15254, the BfaI site at np 4914, the NlaIII sites at nps 4216
and 4577, and the MseI site at 14766. The A!G sequence
polymorphism at np 12308 in the tRNALeu gene was also
tested by using a mismatched primer, which generates aHinfI
site when the A12308G mutation is present [14].
2.3. Oxygen consumption and rotenone sensitivity
Oxygen consumption was measured in intact cells (sam-
ples of 5 106 cells in 2 ml of DMEM lacking glucose,
supplemented with 5% dialyzed FBS at 37 jC) with a YSI
5300 oxymeter (YSI Instruments, Yellow Springs, OH)
[19,20]. Each clone was assessed in at least three independent
experiments, and results are expressed as meanF standard
deviation. The sensitivity of the lines carrying the different
haplogroups to the complex I inhibitor rotenone was assessed
as described [21]. After testing the effects of a wide range of
rotenone concentrations (5 nM–0.1 mM), we chose the
concentration range of 5–500 nM for the subsequent experi-
ments: the cells were treated with different concentrations (5,
10, 20, 40, 100 and 500 nM) of rotenone for 4 h, then were
harvested and the endogenous cell respiration was measured
in whole cells as detailed above. Results are expressed as
percentage of remaining cell respiration.
2.4. Growth curves
Cell growth was assessed in glucose-free/galactose +me-
dium (Gibco) [22]. Multiple series of 60 mm Petri dishes
Table 1
Haplogroup classification of mtDNAs from the osteosarcoma 143B.TK-
parental cell line and control fibroblasts
Sample Haplogroup RFLP Haplotypea,b
143B.TK- X 1715c; + 14465s; + 15397j; + 16517e
PC H  6920c; 7025a; 14766u;  16303k
PS T + 4216q; + 4914r; + 10727c;
+ 13366m/13367b/ + 13367j;
+ 15606a; 15925i; + 16517e
GA J + 4216q; + 10394c; 13704t; 16065g
a Sites are numbered from the first nucleotide of the recognition
sequence. A ‘‘ + ’’ indicates the presence of a restriction site, a ‘‘ ’’ indicates
the absence. The explicit indication of the presence/absence of a site implies
the absence/presence in haplotypes not so designated. The restriction
enzymes used in the analysis are designated by the following single-letter
codes: a, AluI; b, AvaII; c DdeI; e, HaeIII; g, HinfI; i,MspI; j,MboI; k, RsaI;
m, BamHI; q, NlaIII; r, BfaI; s, AccI; t, BstOI; u,MseI. An oblique separating
states indicates the simultaneous presence or absence of restriction sites
that can be correlated with a single nucleotide substitution.
b Sites diagnostic of haplogroups are underlined.
V. Carelli et al. / Biochimica et Biophysica Acta 1588 (2002) 7–148
were seeded each with a constant number of cells (105) in
glucose-free/galactose +medium: DMEM with L-glutamine
without D-glucose, 0.9 mg/ml galactose, 10% dFBS. Dupli-
cate dishes were trypsinized and counted daily for 7 days.
Values obtained from fibroblast derived cybrid clones were
compared to those for the parental 143B.TK-cell line.
Measurements for each haplogroup were repeated at least
in quadruplicate, and results are expressed for each time
point as meanF standard deviation.
2.5. Enzymatic activities
Cytochrome c oxidase (COX) and citrate synthase activ-
ities were assayed spectrophotometrically on freshly har-
vested and sonicated cells as described elsewhere [20]. COX
activity was divided by the citrate synthase activity of that
sample (citrate synthase ratio) to minimize the effects of
variability in mitochondrial mass in the various cell culture
samples.
2.6. Statistical analysis
One-way analysis of variance (ANOVA) was used to test
for statistically significant differences (P < 0.05) between
cybrid cell lines with different mtDNA haplogroups or
between cybrids and the 143B.TK-parental cell line.
3. Results
On the basis of RFLP analysis (Table 1), we selected
three fibroblast cell lines: one belonging to haplogroup J
(HGA-haplo J), the second belonging to haplogroup T
(HPS-haplo T), and the third belonging to haplogroup H
Fig. 1. Oxygen consumption. (A) The averaged oxygen consumption of all the clones derived from each of the fibroblast cell lines used as donors of
mitochondria are compared. No differences are observable among the four mtDNA haplogroups investigated. (B) Clone by clone analysis reveals certain
variability in oxygen consumption. However, only the haplogroup T clone HPS11 tested significantly reduced at ANOVA.
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(HPC-haplo H), the most common (about 40%) haplogroup
in Europe. The RFLP analysis showed that the 143B.TK-
parental cell line harbored a mtDNA belonging to hap-
logroup X. All polymorphisms, including those putatively
LHON-related, were found to be homoplasmic as expected.
The three fibroblast-cell lines selected were then used to
construct the cybrid cell lines. Four clones from each cybrid
cell line were chosen for further investigations (HPC1, 5, 7,
10; HPS1, 3, 6, 11; HGA1, 2, 4, 13). Each of these clones
was maintained for several months and haplogroup-specific
RFLP markers were repeatedly checked to confirm that the
mitochondrial re-population was with the expected
mtDNAs.
The results of oxygen consumption studies are shown in
Fig. 1. There were no significant differences in respiratory
capacity among fibroblast-derived cybrid cell lines or
between any of them and the parental 143B.TK-cell line
(Fig. 1A). Although we observed some interclonal varia-
bility (Fig. 1B), we found no significant differences by
clone-to-clone comparison, except for one single clone with
haplogroup T (HPS11, Fig. 2B). The interclonal variability
is a known phenomenon in cybrid studies even in control
cell lines. It has been suggested that it probably relates to
some nuclear variability of the recipient 206 rho0 cell line,
and it is not correlated to mtDNA content or growth rate,
thus does not affect the general interpretation of the mean
values obtained [22,23].
In order to explore even slight differences in complex I
function that might not be reflected in its specific enzymatic
activity, as happens for 11778/ND4 and 14484/ND6 LHON
pathogenic mutations [24,25], we chose to test cybrid
respiration sensitivity to the complex I specific inhibitor
rotenone. Treatment of the cybrid cell lines with rotenone
caused a dose-dependent inhibition of endogenous cell
respiration in all tested lines (Fig. 2). The inhibition was
slightly more marked in the parental 143B.TK-line (32.6%
of baseline oxygen consumption with no inhibitor) com-
pared to the fibroblast derived cybrids (40–46%). There
was no difference in rotenone sensitivity amongst the
fibroblast-derived lines carrying the three different hap-
logroups. These results suggest that complex I function
was not significantly affected by the different sets of poly-
morphisms in ND subunits defining the three haplogroups
here investigated.
There was also no difference in citrate synthase normal-
ized COX activity among cybrid clones belonging to the
various mtDNA haplogroups and between them and the
parental line 143B.TK (Table 2). COX activity was the only
respiratory complex previously reported to be clearly
affected by haplogroup differences [18].
In order to disclose more subtle defects of respiratory
function among the cybrid cell lines under investigation,
growth experiments were carried out in a glucose-free/
galactose +medium which is a reliable way of testing the
respiratory chain-dependent metabolic capacity of cells [22].
Cybrid cell growth in glucose free/galactose +medium (Fig.
3) also failed to show any substantial difference among the
clones investigated. However, the haplogroup T growth
capacity was at the lower end of the range.
Fig. 2. Effect of complex I inhibition on endogenous cell respiration: values are expressed as percentage of baseline (no rotenone) cell O2 consumption. The
degree of endogenous cell respiration in presence of growing concentration of the complex I inhibitor rotenone is not different among the different lines.
Table 2
COX activity in cybrid clones
143B.TK- HPC-haplo H HPS-haplo T HGA-haplo J
Cytochrome
c oxidase
0.98 (0.25) 0.99 (0.37) 1.06 (0.46) 1.10 (0.47)
Enzyme activity is expressed as citrate synthase ratio. Values are mean of at
least three separate experimentsF (S.D.).
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Fig. 3. Cell growth in glucose-free/galactose+medium. In each graph, the parental 143B.TK-line is compared with cybrids belonging to a different haplogroup.
Each point corresponds to the mean of cell countsF S.D. at that time after seeding. All the cell lines were able to increment their number in this medium, with a
pattern which did not significantly differ from the parental 143B.TK-line.
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4. Discussion
Our study, using a cybrid cellular model, does not reveal
any significant overall respiratory defect in both hap-
logroups J and T cybrids. Few scenarios may be considered.
The first is that more subtle functional changes are
induced by specific haplogroups, and these may in turn
become relevant and observable only through the interaction
with particular environmental conditions and/or nuclear
background or tissue-specific nuclear expression. Wallace
et al. [2] recently speculated that haplogroup J might induce
a partially uncoupling effect on oxidative phosphorylation.
This may be difficult to demonstrate using the experimental
model of cybrid cells. However, others and we have been
recently able to demonstrate a clear growth impairment,
using the galactose medium, of cybrid cells harboring each
of the LHON pathogenic mutations 11778/ND4, 3460/ND1
and 14484/ND6 [22] (Carelli V, Vergani L, Martinuzzi A,
unpublished data). A defective oxidative phosphorylation
has been difficult to demonstrate in LHON-derived cybrid
cell lines, particularly for the 14484/ND6 mutation that
showed only 10–15% reduction in respiration rate [26].
Thus, growth in galactose medium proved to be sensitive
enough to unmask the defective phenotype induced by
LHON pathogenic mutations.
A second scenario is that haplogroup J polymorphisms
are functionally neutral unless the superimposition of a
LHON pathogenic mutation occurs. In a previous study
with LHON-derived cybrid cell lines, we showed that clones
carrying the 11778-haplo J genotype had lower oxygen
consumption and higher doubling time than those with the
11778-non J mtDNA [20]. Multiple cybrid cell clones,
derived from a further individual with the same 11778-
haplo J mitochondrial genome, are currently under inves-
tigation and they showed a milder defect, more similar to the
defects observable in 11778-non J subjects (Carelli V,
Vergani L, Martinuzzi A, unpublished data). To investigate
the same issue, Lodi et al. [27] used 31P MR spectroscopy to
evaluate muscle and brain respiratory function ‘‘in vivo’’ in
ten 11778-haplo J and ten 11778-non J individuals. This
study failed to show any significant differences between the
two groups, although both were clearly deficient compared
to controls [27]. Thus, the co-occurrence of haplogroup J
with the 11778 mutation does not seem to further worsen
mitochondrial respiratory function in cybrid cell lines or ‘‘in
vivo’’. However, it must be kept in mind that LHON
pathology is essentially limited to retinal ganglion cells
[11] and cybrid cell studies nor 31P MR spectroscopy studies
of muscle and brain are truly indicative of the affected
tissue. Thus, although unlikely, it cannot be formally
excluded that haplogroup-specific differences in mitochon-
drial respiratory function might be observable only in the
retinal ganglion cells.
Only one study of Finnish families systematically com-
pared LHON sub-classified by haplogroups [28]. No major
clinical differences were observed between 11778-haplo J
and 11778-non J individuals, in agreement with other
studies in different populations [7,16]. However, penetrance
(males and females combined) was somewhat higher in the
11778-J families as well as, paradoxically, the frequency of
visual recovery (see Table 3 in Ref. [28] and Table 7 in Ref.
[29]). Furthermore, a case of remarkable visual recovery
was reported in a single Italian patient carrying the 11778-
haplo J [30]. A higher male penetrance in 11778-haplo J
families was also reported for the Australian LHON families
[31]. In our experience, the 11778-haplo J families were
homoplasmic, larger and with higher penetrance compared
to the 11778-non J (Carelli V. and Barboni P., unpublished
data).
The association of the 14484/ND6 mutation with hap-
logroup J is even tighter than that of the 11778/ND4
mutation. To date, there are no comparative studies of
14484-haplo J versus 14484-non J families. However, the
visual recovery frequently observed in Europeans with
14484/ND6 mutation does not seem to be associated with
haplogroup J. Indeed, the occurrence of 14484/ND6 muta-
tion in African and Japanese cases is still associated with a
visual recovery [32,33]. Moreover, the biochemical pheno-
type induced by the 14484/ND6 mutation was not affected
by differences in mtDNA background [25]. The European
cases of LHON with 14484/ND6 mutation are frequently
represented by large homoplasmic multigenerational pedi-
grees [11], and in some occasions the association with
haplogroup J may relate to a common founder as for the
Canadian families of French ancestry [34]. However, in
other European populations, haplotype analysis has con-
firmed multiple independent origins of this mutation
[13,14].
We believe there is need to investigate further the
scenarios we outlined. A systematic comparative investiga-
tion of LHON pedigrees harboring 11778/ND4 and 14484/
ND6 mutations associated or not to haplogroup J appears
necessary to resolve the contradictory and anecdotal obser-
vations available so far. The comparison should consider
penetrance and rate of spontaneous visual recovery, espe-
cially for the 11778-haplo J combination. Moreover, pene-
trance should be differentially evaluated between males and
females, since the males are more frequently affected with
LHON, but penetrance in females, who transmit their
mtDNA, is the critical parameter for selective pressure and
persistence of LHON pathogenic mutations in the popula-
tion. Indeed, it would be important to investigate the
persistence of LHON mutations in the population in relation
to mtDNA haplogroups.
This last point is raised because of a third, unconven-
tional scenario that may be suggested by the recently
reported association of haplogroup J with successful aging
[17], and high complex I activity found in spermatozoa with
this haplogroup (see Fig. 5 in Ref. [18]). If haplogroup J
exerts a protective rather than detrimental effect, this could
lead to longer persistence of LHON mutations in the
population. Interestingly, the highest male/female ratio (7–
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8:1), an indirect indication of lower penetrance in females,
was reported for the 14484/ND6 mutation [35–37]. This
mutation may also be persistent in the population, as shown
by the French-Canadian families with haplogroup J [34,37].
The recognition of the 11778/ND4 and 14484/ND6 LHON
mutations in association with haplogroup J, according to
this hypothesis, would be favored compared to the occur-
rence of these mutations in other background mtDNAs. As a
consequence, the 11778/ND4-haplo J and 14484/ND6-
haplo J LHON families should be more frequently large
and homoplasmic rather than small, heteroplasmic pedigrees
or sporadic cases. The unexpectedly high percentage of
sporadic cases reported in some populations for the most
frequent 11778/ND4 mutation provides a good opportunity
to test this hypothesis [14,35,36,38]).
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